icatibant acetate

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 138614-30-9

Where It Comes From

23 FDA-registered drug labelers
Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals Limited
AmbioPharm, Inc.
Assia Chemical Industries Ltd - Teva Tech Site
Aurobindo Pharma Limited
Azico Biophore India Private Limited
Bachem AG
BCN PEPTIDES SA
Bryant Ranch Prepack
Chengdu Shengnuo Biopharm Co. Ltd.
Cipla USA Inc.
Cycle Pharmaceuticals Ltd-Uk
Dr.Reddy's laboratories Limited
Eugia US LLC
FRESENIUS KABI IPSUM SRL
Fresenius Kabi USA, LLC
Hikma Pharmaceuticals USA Inc.
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
MSN Life Sciences Private Limited
SUN PHARMACEUTICAL INDUSTRIES, INC.
Takeda Pharmaceuticals America, Inc.
Teva Pharmaceuticals USA, Inc.
USV Private Limited

Why It Matters

Sectors
Health
Downstream Uses

Appears in 3 drug and cosmetic product listings (FDA).

  • Icatibant
  • Firazyr
  • Sajazir
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS138614-30-9
PubChem CID6918172
DTXSIDDTXSID201027613
FormulaC61H93N19O15S
Mol. Weight1364.6 g/mol
SMILESCC(=O)O.C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O

Data Sources

69181722026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/icatibant acetate/cids/JSON

Archive: data/sources/pubchem_name/icatibant acetate.json

CAS 138614-30-92026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

bulk match2026-04-07

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json